Shang-Zhong Xu

7PUBLICATIONS
9CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Haematological tumoursMolecular targetsPublic health nutritionRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 29, 2024
Molecular Aspects of Cardiovascular Risk Factors.

Shang-Zhong Xu, Thozhukat Sathyapalan

|Jun 28, 2023
Ca2+ Influx through TRPC Channels Is Regulated by Homocysteine-Copper Complexes.

Gui-Lan Chen, Bo Zeng, Hongni Jiang

|Feb 19, 2021
Protective effects of dapagliflozin against oxidative stress-induced cell injury in human proximal tubular cells.

Nawel Zaibi, Pengyun Li, Shang-Zhong Xu

|Oct 02, 2020
Recent advances in drug discovery for diabetic kidney disease.

Chhanda Charan Danta, Andrew N Boa, Sunil Bhandari

|Sep 15, 2020
Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis.

Dong-Na Su, Shi-Pin Wu, Shang-Zhong Xu

|Jul 05, 2019
Mibefradil, a T-type Ca2+ channel blocker also blocks Orai channels by action at the extracellular surface.

Pengyun Li, Hussein N Rubaiy, Gui-Lan Chen

Pageof 2

Frequent Collaborators

2 joint publications

Thozhukat Sathyapalan

1 joint publications

Stephen L Atkin

1 joint publications

Maria F Gomez

1 joint publications

Hussein N Rubaiy